Market Overview:
According to our latest study on "Hemostasis Analyzers Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Product Type, Test, and End User," the market is projected to reach US$ 6,490.24 million by 2028 from US$ 3,440.66 million in 2021; it is expected to register a CAGR of 9.5% from 2021 to 2028. The report highlights the key factors driving the market and prominent players with their developments in the market.
Get Sample PDF: https://www.theinsightpartners.com/sample/TIPRE00016709/
Older people are prone to heart diseases due to weak immunity and other health problems. General aging factors lead to stiffening heart and blood vessels that result in heart disorders. As the age grows, the systolic blood pressure also rises, leading to cardiovascular diseases (CVDs). Thus, in people aged 75 years and above, high blood pressure is a common risk factor for heart conditions. Coronary artery disease and heart failure are the others. Although the incidence of arrhythmias encompasses people of all age groups, it is rising significantly among the geriatric population.
According to the Global Ageing 2019 survey, the world's population of 65 years and above totaled 703 million in 2019. The senior demographic is expected to double to 1.5 billion people by 2050. The frequency of one person with age 65 or more is likely to increase from 1 in every 11 inhabitants in 2019 to 1 in every 6 inhabitants by 2025. This demographic is more susceptible to CVDs, such as arrhythmias. Similarly, according to the World Health Organization (WHO), the percentage of people aged 60 and above is estimated to reach 22% by 2050 from 12% in 2015. As per the report "Older Americans 2016: Key Indicators of Well-Being" by the Federal Interagency Forum on Aging-Related Statistics, 35.8% of individuals aged 85 and above had a mild or extreme cognitive disorder. Moreover, according to the United Nation's World Population Ageing 2017 report, in 2017, 962 million people were aged 60 years or over worldwide, and the number is expected to reach nearly 2.1 billion by 2050.
Based on tests, the hemostasis analyzers market is segmented into activated partial thromboplastin time, D-Dimer test, fibrinogen test, prothrombin time test, and others. In 2021, the activated partial thromboplastin time segment held the largest share of the market and is expected to register the highest CAGR in the market during 2021–2028
Siemens AG; Instrumentation Laboratory; Abbott; Sysmex Corporation; Nihon Kohden Corporation; Thermo Fisher Scientific, Inc.; Roche Diagnostics; Diagnostica Stago; Helena Laboratories; and International Technidyne Corporation are among the leading companies operating in the hemostasis analyzers market.
Buy Now: https://www.theinsightpartners.com/buy/TIPRE00016709/
The report segments the hemostasis analyzers market as follows:
The hemostasis analyzers market is segmented based on product type, test, and end-user. Based on product type, the hemostasis analyzers market is segmented into laboratory analyzers and point-of-care testing systems. Based on the test, the market is segmented into activated partial thromboplastin time, D-dimer test, fibrinogen test, prothrombin time test, and others. Based on end users, the market is segmented into hospitals/clinics, independent diagnostic laboratories, home care settings, and others.
In terms of geography, the hemostasis analyzers market is segmented into North America (the US, Canada, and Mexico), Europe (France, Germany, Italy, the UK, Spain, and the Rest of Europe), Asia Pacific (Australia, China, India, Japan, South Korea, and the Rest of APAC), the Middle East & Africa (Saudi Arabia, South Africa, the UAE, and the Rest of MEA), and South and Central America (Brazil, Argentina, and the Rest of SCAM).
About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.
Contact Us:
If you have any queries about this report or if you would like further information, please contact us:
Contact Person: Sameer Joshi
E-mail: sales@theinsightpartners.com
Phone: +1-646-491-9876
